FORMULATION AND EVALUATION OF FLOATING DRUG DELIVERY OF CEFOTAXIME USING RAFT FORMING APPROACH
The cefotaxime is a broad-spectrum cephalosporin antibiotic. It is mainly used in the treatment of bacterial infections. Cefotaxime is a suitable candidate for controlled release administration due to its short elimination time 1 hour. The main aim of the present investigation is to increase the gastric residence time by preparing floating drug delivery by using raft forming approach thereby improving bioavailability. The prepared Cefotaxime floating drug delivery by using raft forming approach were evaluated for hardness, weight variation, thickness, friability, drug content uniformity, total floating time, In-vitro dissolution studies and buoyancy lag time. Floating tablets were formulated using direct compression technique. Various polymers are used in the formulation they Microcrystalline cellulose used as binder, HPMC K15M, Guargum used as hydrophilic polymers, Chitosan, Sodium bicarbonate was incorporated as an effervescent substance, Sodium alginate used as viscous gel forming agent, Magnesium streate used as lubrication, talc was used as diluent. The formulated Cefotaxime tablet to be evaluated the following parameters as follow Weight variation (mg), Hardness, Thickness, Friability, Drug content uniformity, Floating lag time, the in vitro cumulative amount of drug released was shown the F7 is 99.28% within 45 minutes the comparative studies with marketed formulations F7 show the better results.
Keywords: Cefotaxime, Direct compression, Raft forming, floating drug delivery system.
2. Dey S, UV Spectrophotometric Determination of Cefixime in Bulk and its Dosage Form, Journal of Pharmacy Research, 2012; 5(12):5419-5422.
3. Janakidevi S, Design and Optimization of Cefixime Trihydrate Sustained Matrix Tablets Using Different Polymers, International Research Journal of Pharmacy, 2014; 7(5):619-625.
4. Streubel A, Siepmann J, Bodmeier R, Drug Delivery to the upper small intestine window using Gastro retentive technologies. Curr Opin Pharmacol, 2006; 6:501-508.
5. Rubinstein, MH, Physiological Pharmaceutical: Biological barriers to the drug absorption. Chichester, U.k: Ellis Horwood. 1989, P.47-70.
6. Whitehead L, Fell JT and Collett JH. Development of a gastroretentive dosage form. Eur J Pharm Sci, 1996; 4:182-188.
7. Birajdar shiv Prasad M, BhusnureOG, S. Mulaje S, formulation and evaluation of fast disintegrating losartan tablets by formal experimental design, international journal of research and development in pharmacy and life sciences, 2014; 3(1):1136-1150.
8. Devareddy S, Krishnarajan D, Manivannan R, Senthilkamar N. Formulation and Evaluation of Losartan Potassium and Hydrochloriazide Conventional Release Tablets, International Research Journal of Pharmacy, 2012; 3(6):159-164.
9. Gehan balata, Formulation and Evaluation of Gastro-retentive Floating Tablet of Nizatidine. International Journal of Pharmacy and Pharmaceutical Sciences, 2014; 6(5):423-429.
10. Haranadh CH, Lokeshreddy M, Vaseedhar B, Sabareesh M, Umasankar K. Formulation and evaluation of hydrogel based oral controlled drug delivery system for losartan potassium. International Journal of Research in Pharmaceutical and Nano sciences, 2014; 3(3):190-199.
11. Patel J, Patel A, Sheth Z, Development of Floating Tablet Containing Roxatidine Acetate by Statistical Optimization Technique, International Journal of Pharmaceutical Science, 2014; 3(5):201-210.
12. Jagadale S K, Patil P S and Navele R, Formulation and Evaluation of Orally Disintergrating Tablet of Losartan Potassium by Direct Compression Method. Research journal of pharmaceutical biological and chemical sciences, 2013; 4(4):127-135.
13. Janimini M, Shrivastava B, Tanwar V.S, Formulation and Evaluation of Effervescent Floating Matrix Tablet of Losartan Potassium, International Journal of Pharmaceutical Innovations, 2011; 1(5):82-87.
14. Katyayini S, Sellappanvelmurugan, Formulation and Evaluation of Effervescent Floating Tablets of Losartan Potassium, International Journal of Pharmacy and Pharmaceutical sciences, 2013; 5(3):559-565.
15. Latha K, Uhumwangho MU, Sunil SA, Srikanth MV, Ramana murthy KV, Formulation and Evaluation of Oral Time Release Tablets of Losartan Potassium Using Natural Gum and its Solid Characterization, 2012; 4(5):89-95.
16. Manjula B, B. Mohammed Ishaq, C. Hari Kumar, Usha Rani G. Formulation and Evaluation of Gastro retentive Floating Drug Delivery System of Ketoprofen. Scholars Research Library, Der Pharmacia Lettre, 2010; 2(3):197-208.
17. Janimini M, Tanwar YS, Srivastava B, Formulation and Evaluation of Gastro Retentive Drug Delivery System of Losartan Potassium, International Current Pharmaceutical Journal, 2012; 2(1):11-17.
18. Chandira M, Bhowmik D, Chiranjib,.Jayakar B, Formulation Evaluation of Gastro retentive Drug Delivery System of Gastroprokinetic drug Itopride hydrochloride, International Journal of Pharmacy and Pharmaceutical Sciences, 2010; 2(1):53-65.
19. Janimini M, Shrivastava B, Tanwar V.S, Formulation and Evaluation of Effervescent Floating Matrix Tablet of Losartan Potassium, International Journal of Pharmaceutical Innovations, 2011; 1(5): 82-87.
20. Katyayini S, Sellappanvel Murugan, Formulation and Evaluation of Effervescent Floating Tablets of Losartan Potassium, International Journal of Pharmacy and Pharmaceutical Sciences, 2013; 5(3):559-565.
21. Keshari A, Tripathi DPK, Srivastava A, Vishwas R, Formulation and evaluation of effervecent floating tablets of antidiabetic drug. Journal of Drug Delivery and Therapeutics. 2015; 5(6):43-55
22. Janimini M, Tanwar YS, Birendrasrivastava, Formulation and Evaluation of Gastro Retentive Drug Delivery System of Losartan potassium, International Current Pharmaceutical Journal, 2012; 2(1):11-17.
23. Manjula B, Formulation and Evaluation Gastro Retentive Floating Drug Delivery System of Ketoprofen, Scholars research library, 2010; 2(3):197-208.
24. Margret chandira R, Debit Bhowmik, Chiranji B, and B. Jayakar, Formulation & Evaluation of Gastro Retentive Drug Delivery System of Gastroprokinetic drug Itopride hydrochloride, International Journal of Pharmacy and Pharmaceutical Sciences, 2010; 2(1):53-65.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).